How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

16,246 results for

Natural Family Planning

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells

Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03634501 Recruitment Status : Recruiting First Posted

2018 Clinical Trials

162. Natural History of GACI With or Without ARHR2 or PXE

Update Posted: November 29, 2018 Last Verified: November 2018 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Layout table for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Additional relevant MeSH terms: Layout table for MeSH terms Calcinosis Rickets Rickets, Hypophosphatemic Familial Hypophosphatemic Rickets Pseudoxanthoma Elasticum Arteriosclerosis Vascular Calcification Calcium Metabolism Disorders (...) Natural History of GACI With or Without ARHR2 or PXE Natural History of GACI With or Without ARHR2 or PXE - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Natural History of GACI With or Without ARHR2 or PXE

2018 Clinical Trials

163. Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency

Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03758521 Recruitment Status : Recruiting

2018 Clinical Trials

164. Avelumab in Relapsed or Refractory Stage III/IV Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY]

Avelumab in Relapsed or Refractory Stage III/IV Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY] Avelumab in Relapsed or Refractory Stage III/IV Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY] - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Avelumab in Relapsed or Refractory Stage III/IV Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY] The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03439501 Recruitment Status : Enrolling by invitation First Posted : February 20, 2018 Last Update

2018 Clinical Trials

165. Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate

Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have (...) reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate (TECNAT) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before

2018 Clinical Trials

166. Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study)

Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study) Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier

2018 Clinical Trials

167. The Natural History of Danon Disease

The Natural History of Danon Disease The Natural History of Danon Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. The Natural History of Danon Disease The safety and scientific validity (...) , MD, University of California, San Diego Study Details Study Description Go to Brief Summary: Danon disease (DD) is a rare, X-linked disorder associated with severe cardiomyopathy, and in many cases, skeletal myopathy, and cognitive impairment caused by mutations in the LAMP2 gene. There is still uncertainty regarding the natural history of DD because of its rarity. This study aims to determine the natural history of DD through the collection and analysis of retrospective and prospective data

2018 Clinical Trials

168. A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy

A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03760029 Recruitment Status : Not yet recruiting First Posted : November 30, 2018

2018 Clinical Trials

169. Dental Caries Prevention by a Natural Product

Dental Caries Prevention by a Natural Product Dental Caries Prevention by a Natural Product - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Dental Caries Prevention by a Natural Product The safety (...) Adults: Randomized Controlled Trial Estimated Study Start Date : December 1, 2018 Estimated Primary Completion Date : December 1, 2019 Estimated Study Completion Date : January 1, 2020 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Licorice licorice is one of the natural products that is listed by the Food and Drug Administration (FDA) as GRAS (generally regarded as safe) when used

2018 Clinical Trials

170. Family Building Through Gestational Surrogacy

Family Building Through Gestational Surrogacy Family Building Through Gestational Surrogacy - ACOG Menu ▼ Family Building Through Gestational Surrogacy Page Navigation ▼ Number 660, March 2016 (Replaces Committee Opinion No. 397, February 2008) Committee on Ethics This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Ethics. Member contributors included Ginny L. Ryan, MD. While this document reflects the current viewpoint of the College (...) , it is not intended to dictate an exclusive course of action in all cases. This Committee Opinion was approved by the Committee on Ethics and the Executive Board of the American College of Obstetricians and Gynecologists. Family Building Through Gestational Surrogacy ABSTRACT: Gestational surrogacy is an increasingly common form of family building that can allow individuals or a couple to become parents despite circumstances in which carrying a pregnancy is biologically impossible or medically contraindicated

2016 American College of Obstetricians and Gynecologists

171. Effective Interventions for Families and Caregivers to Reduce Tobacco Second-hand Smoke Exposure in Homes: A Rapid Review

outcomes for children, parents, and the family as a whole. Peel Public Health has set Living Tobacco-Free and Nurturing the Next Generation as two strategic priorities in their 10-Year Strategic Plan (2009-19). These priorities were reaffirmed in the 2014-2019 Setting the Pace Strategic Plan. Methods and Results of the Literature Review The search of published and grey literature yielded 400 articles. After assessing relevance and critical appraisal, a World Health Organization (WHO) guideline (2013 (...) Effective Interventions for Families and Caregivers to Reduce Tobacco Second-hand Smoke Exposure in Homes: A Rapid Review Effective interventions for families and caregivers to reduce tobacco second-hand smoke exposure in homes A Rapid Review Nadia Lapczak, Analyst, Research and Policy, Family Health Dawn Machado, Supervisor, Family Health November 14, 2016 1 Table of Contents Key Messages 2 Executive Summary 3 1 Issue 5 2 Context 6 3 Conceptual Model 7 4 Literature Review Question 8 5

2016 Peel Health Library

172. The Agenda for Familial Hypercholesterolemia (Full text)

for confirmation of the diagnosis. , , Drawing of a pedigree (family tree) can be valuable in planning cascade screening in families. Cascade screening should start with first-degree relatives and then be extended to second- and third-degree relatives. , , Relatives may be approached, with appropriate consent, by the index case, the clinical service, or both. , , Dual risk notification may be the best option. , , All communications must be lucid and must emphasize the health gains of diagnosis and treatment (...) The Agenda for Familial Hypercholesterolemia The Agenda for Familial Hypercholesterolemia | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump

2015 American Heart Association PubMed abstract

173. Person-and Family-Centred Care

obtained on the meaning and experience of health to the person using the person’s own words . V NEW10 REGISTERED NURSES’ ASSOCIATION OF ONTARIO BACKGROUND Person- and Family-Centred Care PRACTICE RECOMMENDATIONS LEVEL OF EVIDENCE STATUS 2.0 Planning Recommendation 2 .1: Develop a plan of care in partnership with the person that is meaningful to the person within the context of their life . Ia NEW Recommendation 2 .2: Engage with the person in a participatory model of decision making, respecting (...) by the Ontario government, this legislation established 14 Local Health Integration Networks (LHIN) responsible for improving local community engagement throughout the province in planning, coordinating, and funding each region’s health services. The Act transferred significant power for making decisions to the community level, enabling local health systems to focus on the needs of individual communities.19 BEST PRACTICE GUIDELINES • www.RNAO.ca BACKGROUND Person- and Family-Centred Care ¦ Primary Health

2015 Registered Nurses' Association of Ontario

174. Psychosis and physical health: listening to patients and family carers

. Can we trust our common sense, and invite family carers into our consultation rooms? Instead of giving clichéd tag-lines (e.g. “you should try to take 10,000 steps a day” ), maybe we can talk about what the patient wants to do, what they may have already tried or are already doing, what they think would work, what we want the patient to do, and how we may be able to meet halfway with the resources and options that we have, and, where it’s OK to do so, include the family carer in the plan. We (...) Psychosis and physical health: listening to patients and family carers Psychosis and physical health: listening to patients and family carers Search National Elf Service Search National Elf Service » » » » Psychosis and physical health: listening to patients and family carers Mar 5 2019 Posted by >, We know the stats. People with psychosis die younger, the is not improving, and most people with psychosis die from chronic physical illness (Saha S. et al., 2007). We also know that family carers

2019 The Mental Elf

175. Examining quality of contraceptive services for adolescents in Oregon's family planning program. (Abstract)

into three tiers: Tier 1 is the intrauterine device, implant and sterilization; Tier 2, hormonal methods; and Tier 3, all barrier methods. Nonmodern methods included no method, withdrawal and natural family planning. We used multivariable logistic regression models to examine the effect of age on three indicators of quality of contraceptive care: transitioning from a nonmodern to a modern method, transitioning from Tier 3 methods to Tier 1 or Tier 2 methods, and initiation of long-acting reversible (...) Examining quality of contraceptive services for adolescents in Oregon's family planning program. To assess the quality of care provided to adolescents (10-19 years old) compared to women (aged 20-25 years) who accessed services in Oregon's Contraceptive Care (CCare) program.We analyzed data routinely collected using the Clinic Visit Record form from women aged 25 years and younger who visited CCare clinics between January 1, 2004, and October 31, 2010. Modern methods were characterized

2014 Contraception

176. Association between family functionality measured by family AGPAR, FACES III, socio familiar scale of Gij¢n, clinical criteria and diagnosis of depression: systematic review and meta-analysis

Association between family functionality measured by family AGPAR, FACES III, socio familiar scale of Gij¢n, clinical criteria and diagnosis of depression: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external (...) . ">Data to be extracted: secondary outcome(s) Example: 1st author, year of publication, language, journal. ">Data to be extracted: other as well as a to meta-analysis of pre-clinical studies are available. Example: A meta‐analysis will be performed for all outcome measures reported in 10 or more articles. For subgroup analysis a minimum of 8 studies per subgroup is required. If meta‐analysis is not possible, data will be reported through a descriptive summary. ">Planned approach Example: number

2018 PROSPERO

177. Safety, effectiveness and cost-effectiveness of genetic testing for heritable mutations associated with familial hypercholesterolaemia in index cases and family members

Safety, effectiveness and cost-effectiveness of genetic testing for heritable mutations associated with familial hypercholesterolaemia in index cases and family members Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (...) outcome(s) Example: 1st author, year of publication, language, journal. ">Data to be extracted: other as well as a to meta-analysis of pre-clinical studies are available. Example: A meta‐analysis will be performed for all outcome measures reported in 10 or more articles. For subgroup analysis a minimum of 8 studies per subgroup is required. If meta‐analysis is not possible, data will be reported through a descriptive summary. ">Planned approach Example: number of metastases: standardized mean

2018 PROSPERO

178. Can screening for the presence of congenital hypertrophy of the retinal pigment epithelium (CHRPE) using a non-invasive eye examination be used as a surrogate to diagnose classic familial adenomatous polyposis (FAP) in those with a positive family history

Can screening for the presence of congenital hypertrophy of the retinal pigment epithelium (CHRPE) using a non-invasive eye examination be used as a surrogate to diagnose classic familial adenomatous polyposis (FAP) in those with a positive family history Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content (...) a descriptive summary. ">Planned approach Example: number of metastases: standardized mean difference; incidence of metastasis: risk ratio. ">Effect measure The random-effects model is the typical model of choice for pre-clinical meta-analyses. This is because in the fixed-effect model, it is assumed that the differences in observed effect between studies is solely due to sampling error (i.e. differences in sample size), and that the true effect is the same (fixed) across all studies. However

2018 PROSPERO

179. The effects of multilingualism in the family on family member's subjective wellbeing

The effects of multilingualism in the family on family member's subjective wellbeing Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing (...) to be extracted: other as well as a to meta-analysis of pre-clinical studies are available. Example: A meta‐analysis will be performed for all outcome measures reported in 10 or more articles. For subgroup analysis a minimum of 8 studies per subgroup is required. If meta‐analysis is not possible, data will be reported through a descriptive summary. ">Planned approach Example: number of metastases: standardized mean difference; incidence of metastasis: risk ratio. ">Effect measure The random-effects model

2018 PROSPERO

180. Beyond simple planning: existential dimensions of conversations with patients at risk of dying from heart failure. (Full text)

Beyond simple planning: existential dimensions of conversations with patients at risk of dying from heart failure. Despite the recent promotion of communication guides to improve decision making with patients nearing the end of their lives, these conversations remain challenging. Deeper and more comprehensive understanding of communication barriers that undermine discussions and decisions with patients at risk of dying from heart failure (HF) is vital for informing communication in health (...) professionals (e.g., cardiologist, family physician, HF nurse practitioner, social worker, and specialists, such as respirologist, nephrologist, palliative care physician), family caregivers (e.g., daughter, spouse, roommate, close friend), and community members (e.g., minister, neighbor, regular taxi driver). Our data set included 209 individual interviews clustered into 50 team sampling units at five sites from three Canadian provinces. Key informants, identified as practicing experts in the field

2017 Journal of pain and symptom management PubMed abstract

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>